BioSpace News Archive

BioForest

BioLife Solutions Expands Intellectual Property Estate

BioLife Solutions, Inc., a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy and the broader biopharma markets, provided an update on the expansion of its intellectual property estate.

November 21, 2022
·
3 min read
Biotech Bay

Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference

Graphite Bio, Inc. today announced that members of the management team will participate in a fireside chat at the Evercore ISI 5th Annual HealthCONx Conference on Thursday, Dec. 1, 2022, at 11:45 a.m. ET.

November 21, 2022
·
1 min read
Genetown

Flare Therapeutics to Present at Piper Sandler 34th Annual Healthcare Conference

Flare Therapeutics today announced that Daphne Karydas, Chief Operating Officer and Chief Financial Officer of Flare Therapeutics, will present a company overview at 9:30 a.m. ET on Thursday, December 1, 2022 at the Piper Sandler 34th Annual Healthcare Conference being held in New York, NY.

November 21, 2022
·
1 min read
Azura Ophthalmics Announces Participation at Upcoming Investor Conferences

Azura Ophthalmics Ltd. today announced that members of management will present at BTIG’s Ophthalmology Day 2022, being held on November 29, and at the Piper Sandler 34th Annual Healthcare Conference, being held from November 29 through December 1.

November 21, 2022
·
3 min read
Pharm Country

Rocket Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference

Rocket Pharmaceuticals, Inc. today announces that Gaurav Shah, M.D., Chief Executive Officer, will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference.

November 21, 2022
·
4 min read
Biotech Bay

Verge Genomics to Present at Upcoming Investor Conferences in November

Verge Genomics announced today that Alice Zhang, CEO and co-founder of Verge Genomics, will present at both the Piper Sandler 34th Annual Healthcare Conference on November 29.

November 21, 2022
·
1 min read
Biotech Beach

Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Has No Clinically Significant Difference in Accuracy or Bias Between Black and White People

Masimo (NASDAQ: MASI) today announced the publication of a peer-reviewed study regarding Masimo SET® pulse oximetry performance in varying skin pigmentation in the Journal of Clinical Monitoring and Computing.

November 21, 2022
·
10 min read
Deals

Asep Medical Holdings Inc. Announces Listing of its Common Shares on the Frankfurt Stock Exchange

Asep Medical Holdings Inc. is pleased to announce its common shares commenced trading on the Frankfurt Stock Exchange (FSE) on November 10, 2022, under the stock symbol FSX: JJ8.

November 21, 2022
·
4 min read
Genetown

PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays

PerkinElmer, Inc. , (NYSE:PKI), a global leader committed to innovating for a healthier world, today launched ready-to-use Adeno-associated Virus Vectors (AAV) Detection Kits to support researchers working on gene therapies for a variety of serious diseases.

November 21, 2022
·
3 min read
Pharm Country

Bristol Myers Squibb Data at ASH 2022 Highlight Innovative Therapeutic Platforms Across a Range of Blood Diseases

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of research across its hematology portfolio at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, which will take place in New Orleans, Louisiana, and virtually, from December 10 to 13, 2022.

November 21, 2022
·
49 min read